ICD-10-CM/PCS MS-DRG v38.0 R1 Definitions Manual

Previous Page [Alt-p] Up a level [Alt-u] Next Page [Alt-n]
Pre-MDC
Chimeric antigen receptor (CAR) T-cell immunotherapy
DRG
018

DRG 018 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY

T-CELL IMMUNOTHERAPY

NON-OPERATING ROOM PROCEDURES

XW033C3*Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 3
XW043C3*Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 3
XW23346*Transfusion of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6
XW23376*Transfusion of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6
XW24346*Transfusion of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6
XW24376*Transfusion of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6



Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244
17 Sep 2020 09:49:17
CMS, code-revision=275, description-revision=1286